Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia

This publication has 24 references indexed in Scilit:

• Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
  American Journal of Obstetrics and Gynecology, 2005
• Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
  The Journal of Maternal-Fetal & Neonatal Medicine, 2005
• Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of Preeclampsia
  Clinical Chemistry, 2004
• Circulating Angiogenic Factors and the Risk of Preeclampsia
  New England Journal of Medicine, 2004
• Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia
  Obstetrics & Gynecology, 2003
• Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria
  Journal of Biological Chemistry, 2003
• Recent Insights into the Pathogenesis of Pre-eclampsia
  Placenta, 2002
• Preeclampsia: is there value in assessing before clinically evident disease?
  Obstetrics & Gynecology, 2001
• Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia
  BJOG: An International Journal of Obstetrics and Gynaecology, 1999
• Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia
  BJOG: An International Journal of Obstetrics and Gynaecology, 1997